Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):756–762. doi: 10.1002/pds.1959

Table 3.

Results of multivariable analysis

Risk factor OR (95% CI) P-value
Age by 10 years
    40-49 0.58 (0.23-1.48) 0.26
    50-59 1.13 (0.68-1.91) 0.63
    60-69 1.0 --
    70-79 0.81 (0.55-1.18) 0.26
    >=80 0.92 (0.59-1.43) 0.71
Sex (female) 1.29 (0.95-1.74) 0.11
Practice experience (quintiles)
    1 1.0 --
    2 0.91 (0.58-1.45) 0.71
    3 1.12 (0.70-1.79) 0.63
    4 0.86 (0.53-1.38) 0.53
    5 0.89 (0.55-1.45) 0.65
Diabetes 0.73 (0.46-1.18) 0.20
Obesity 1.05 (0.68-1.63) 0.82
HTN or CHF* 0.79 (0.56-1.11) 0.17
PUD or GIB** 0.86 (0.48-1.53) 0.61
Glaucoma/cataract 0.89 (0.58-1.37) 0.60
Osteoporosis 0.97 (0.63-1.49) 0.90
Smoking 0.81 (0.57-1.15) 0.24
Past ILD 0.97 (0.54-1.72) 0.91
Asthma or COPD*** 0.71 (0.48-1.05) 0.09
Dyspnea 1.33 (0.97-1.80) 0.07
Cough 1.00 (0.74-1.35) 0.99
Oxygen use 1.68 (1.14-2.49) 0.009
Past steroid use 1.64 (1.13-2.38) 0.010
Recent steroid use 5.79 (3.84-8.74) <0.001

Reference category

*

Hypertension or congestive heart failure

**

Peptic ulcer disease or gastrointestinal bleeding

***

Chronic obstructive pulmonary disease

Interstitial lung disease other than IPF